Ziegler Christoph Samuelinsider trades

In SEC Form 4 filings, Ziegler Christoph Samuel is listed as Director of Veraxa Biotech AG - Post de-SPAC (VRXA). In the last 90 days, Ziegler Christoph Samuel bought $32.7K of Veraxa Biotech AG - Post de-SPAC (VRXA) on the open market and sold none. The purchase was $32.7K of Veraxa Biotech AG - Post de-SPAC (VRXA) on Oct 20.

Companies and roles

Company	Role	Transactions	Last filed
VRXAVeraxa Biotech AG - Post de-SPAC	Director	1	Oct 21

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
VRXAVeraxa Biotech AG - Post de-SPAC	Oct 20	Oct 21	P	30,000	$1.09	Purchase +$32,700	37,932	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.